Long-term Survival After Diverse Therapeutic Modalities in Malignant Phyllodes Tumors of the Breast

Background and Objects: Malignant phyllodes tumor of the breast (MPTB) is a rare tumor for which surgery or surgery combined with radiotherapy (RT) is the primary treatment method. However, recently, the therapeutic effect of RT on MPTB has been controversial. We aimed to explore the role of RT, che...

Full description

Bibliographic Details
Main Authors: Hongyi Zhang MD, Shasha Tang MD, Ewelina Biskup MD, Yi Zhang MD, Liyun Yong MD, Lijun Chen MD, Fengfeng Cai MD
Format: Article
Language:English
Published: SAGE Publishing 2022-08-01
Series:Technology in Cancer Research & Treatment
Online Access:https://doi.org/10.1177/15330338221121086
_version_ 1797689782013263872
author Hongyi Zhang MD
Shasha Tang MD
Ewelina Biskup MD
Yi Zhang MD
Liyun Yong MD
Lijun Chen MD
Fengfeng Cai MD
author_facet Hongyi Zhang MD
Shasha Tang MD
Ewelina Biskup MD
Yi Zhang MD
Liyun Yong MD
Lijun Chen MD
Fengfeng Cai MD
author_sort Hongyi Zhang MD
collection DOAJ
description Background and Objects: Malignant phyllodes tumor of the breast (MPTB) is a rare tumor for which surgery or surgery combined with radiotherapy (RT) is the primary treatment method. However, recently, the therapeutic effect of RT on MPTB has been controversial. We aimed to explore the role of RT, chemotherapy (CT), and surgical modalities in patients with MPTB. Methods: The Surveillance, Epidemiology, and End Results (SEER) database was used to select patients with MPTB who met the criteria between 2010 and 2018. Kaplan–Meier curves and Cox proportional risk regression models were used to analyze the effects of RT on MPTB patients. Based on this, we compared the effects of breast-conserving surgery (BSC) and mastectomy on the postoperative survival of MPTB. Results: A total of 298 patients with MPTB were included in this study. RT was received by 22.1% (n  =  66) of the patients while 77.9% (n  =  232) did not receive RT. CT was received by 4.7% (n  =  14) patients while 95.3% (n  =  284) did not receive CT. According to Kaplan–Meier curves, RT and CT combined resulted in a decrease in breast cancer-specific survival (BCSS) and overall survival (OS) compared to patients who did not receive RT. Mastectomy improved the OS and BCSS of the patients more than BCS). The findings of univariate and multivariate Cox regression analyses suggested that “distant metastasis”, “tumor grade” and “number of positive lymph node biopsies” affected OS of breast cancer, while “distant metastasis”, “tumor grade”, “surgery combined with radiotherapy/surgery”, and “radiotherapy/chemotherapy or not”, had a significant effect on BCSS. Conclusion: RT and CT did not significantly improve the long-term survival of MPTB patients. Mastectomy improved OS and BCSS of the patient more than BCS. RT in an early stage improved early prognosis moderately in MPTB patients with tumor diameter less than 50 mm.
first_indexed 2024-03-12T01:51:20Z
format Article
id doaj.art-7f4c17951a7143d48ce1de2524553042
institution Directory Open Access Journal
issn 1533-0338
language English
last_indexed 2024-03-12T01:51:20Z
publishDate 2022-08-01
publisher SAGE Publishing
record_format Article
series Technology in Cancer Research & Treatment
spelling doaj.art-7f4c17951a7143d48ce1de25245530422023-09-08T13:34:46ZengSAGE PublishingTechnology in Cancer Research & Treatment1533-03382022-08-012110.1177/15330338221121086Long-term Survival After Diverse Therapeutic Modalities in Malignant Phyllodes Tumors of the BreastHongyi Zhang MD0Shasha Tang MD1Ewelina Biskup MD2Yi Zhang MD3Liyun Yong MD4Lijun Chen MD5Fengfeng Cai MD6 Department of Breast Surgery, School of Medicine, Yangpu Hospital, , Shanghai, China Department of Breast Surgery, School of Medicine, Yangpu Hospital, , Shanghai, China , Shanghai, PR China Department of Breast Surgery, School of Medicine, Yangpu Hospital, , Shanghai, China Department of Breast Surgery, School of Medicine, Yangpu Hospital, , Shanghai, China Department of Oncology, , Fudan University, Shanghai, China Department of Breast Surgery, School of Medicine, Yangpu Hospital, , Shanghai, ChinaBackground and Objects: Malignant phyllodes tumor of the breast (MPTB) is a rare tumor for which surgery or surgery combined with radiotherapy (RT) is the primary treatment method. However, recently, the therapeutic effect of RT on MPTB has been controversial. We aimed to explore the role of RT, chemotherapy (CT), and surgical modalities in patients with MPTB. Methods: The Surveillance, Epidemiology, and End Results (SEER) database was used to select patients with MPTB who met the criteria between 2010 and 2018. Kaplan–Meier curves and Cox proportional risk regression models were used to analyze the effects of RT on MPTB patients. Based on this, we compared the effects of breast-conserving surgery (BSC) and mastectomy on the postoperative survival of MPTB. Results: A total of 298 patients with MPTB were included in this study. RT was received by 22.1% (n  =  66) of the patients while 77.9% (n  =  232) did not receive RT. CT was received by 4.7% (n  =  14) patients while 95.3% (n  =  284) did not receive CT. According to Kaplan–Meier curves, RT and CT combined resulted in a decrease in breast cancer-specific survival (BCSS) and overall survival (OS) compared to patients who did not receive RT. Mastectomy improved the OS and BCSS of the patients more than BCS). The findings of univariate and multivariate Cox regression analyses suggested that “distant metastasis”, “tumor grade” and “number of positive lymph node biopsies” affected OS of breast cancer, while “distant metastasis”, “tumor grade”, “surgery combined with radiotherapy/surgery”, and “radiotherapy/chemotherapy or not”, had a significant effect on BCSS. Conclusion: RT and CT did not significantly improve the long-term survival of MPTB patients. Mastectomy improved OS and BCSS of the patient more than BCS. RT in an early stage improved early prognosis moderately in MPTB patients with tumor diameter less than 50 mm.https://doi.org/10.1177/15330338221121086
spellingShingle Hongyi Zhang MD
Shasha Tang MD
Ewelina Biskup MD
Yi Zhang MD
Liyun Yong MD
Lijun Chen MD
Fengfeng Cai MD
Long-term Survival After Diverse Therapeutic Modalities in Malignant Phyllodes Tumors of the Breast
Technology in Cancer Research & Treatment
title Long-term Survival After Diverse Therapeutic Modalities in Malignant Phyllodes Tumors of the Breast
title_full Long-term Survival After Diverse Therapeutic Modalities in Malignant Phyllodes Tumors of the Breast
title_fullStr Long-term Survival After Diverse Therapeutic Modalities in Malignant Phyllodes Tumors of the Breast
title_full_unstemmed Long-term Survival After Diverse Therapeutic Modalities in Malignant Phyllodes Tumors of the Breast
title_short Long-term Survival After Diverse Therapeutic Modalities in Malignant Phyllodes Tumors of the Breast
title_sort long term survival after diverse therapeutic modalities in malignant phyllodes tumors of the breast
url https://doi.org/10.1177/15330338221121086
work_keys_str_mv AT hongyizhangmd longtermsurvivalafterdiversetherapeuticmodalitiesinmalignantphyllodestumorsofthebreast
AT shashatangmd longtermsurvivalafterdiversetherapeuticmodalitiesinmalignantphyllodestumorsofthebreast
AT ewelinabiskupmd longtermsurvivalafterdiversetherapeuticmodalitiesinmalignantphyllodestumorsofthebreast
AT yizhangmd longtermsurvivalafterdiversetherapeuticmodalitiesinmalignantphyllodestumorsofthebreast
AT liyunyongmd longtermsurvivalafterdiversetherapeuticmodalitiesinmalignantphyllodestumorsofthebreast
AT lijunchenmd longtermsurvivalafterdiversetherapeuticmodalitiesinmalignantphyllodestumorsofthebreast
AT fengfengcaimd longtermsurvivalafterdiversetherapeuticmodalitiesinmalignantphyllodestumorsofthebreast